Skip to content

Sarcopenia And Balance In Postmenopausal Osteoporosis

Sarcopenia And Balance In Postmenopausal Osteoporosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03832088
Enrollment
53
Registered
2019-02-06
Start date
2018-08-01
Completion date
2019-03-31
Last updated
2019-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, Postmenopausal, Balance; Distorted, Sarcopenia

Keywords

osteoporosis, sarcopenia, balance disorder

Brief summary

The study was performed on 53 postmenopausal osteoporosis patients who presented to our osteoporosis outpatient clinic. Following written informed consent, patients were evaluated for sarcopenia according to the sarcopenia algorithm proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). Algorithm parameters were walking speed, muscle strength and muscle mass measurements. We used Timed Up and Go Test (TUG) for evaluation of walking speed, Jamar Hand Dynamometer for muscle strength assessment, and calf circumference for muscle mass measurement. Balances of the patients were evaluated with Berg Balance Scale (BBS) and functional skills were evaluated with the Timed Up and Go Test (TUG). Other clinical parameters (age, body mass index (BMI), 25OHvitD level, menopause age, fall within the last year, fracture history, history of fracture in mother) were questioned.

Detailed description

The study was performed on 53 postmenopausal osteoporosis patients who presented to our osteoporosis outpatient clinic. Following written informed consent, patients were evaluated for sarcopenia according to the sarcopenia algorithm proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). Algorithm parameters were walking speed, muscle strength and muscle mass measurements. We used Timed Up and Go Test (TUG) for evaluation of walking speed, Jamar Hand Dynamometer for muscle strength assessment, and calf circumference for muscle mass measurement. Balances of the patients were evaluated with Berg Balance Scale (BBS) and functional skills were evaluated with the Timed Up and Go Test (TUG). Other clinical parameters (age, body mass index (BMI), 25OHvitD level, menopause age, fall within the last year, fracture history, history of fracture in mother) were questioned. SPSS 22.0 program will be used for statistical evaluation and correlation analysis will be done.

Interventions

DIAGNOSTIC_TESTBerg Balance Scale

Berg Balance Scale performed for balance disorder

DIAGNOSTIC_TESTTimed Up and Go Test

Timed Up and Go Test for walking speed

DIAGNOSTIC_TESTJamar hand dynamometer

Jamar hand dynamometer for grip strength which correlates with muscle strength of patient

DIAGNOSTIC_TESTCalf circumference

Calf circumference for muscle mass evaluation. Calf circumference is an anthropometric measurement which correlates with muscle mass.

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Having postmenopausal osteoporosis * No other disease that can cause balance disorder * Volunteer participation in the study

Exclusion criteria

* To have a disease that will cause balance disorder, * Having understanding problem to prevent communication with the patient, * The lack of motor function to the balance device.

Design outcomes

Primary

MeasureTime frameDescription
sarcopenia in postmenopausal osteoporotic patients6 monthssarcopenia evaluated according to EWGSOP algorithm which includes walking speed, muscle strength and muscle mass measures
balance disorder in postmenopausal osteoporotic patients6 monthsbalance evaluated by Berg Balance Scale ( 0-56 scored scale , bigger score indicates better balance, scores under 41 indicates bigger risk of falling )

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026